Patent "Reform" Will Undermine Small Business


By Karen Kerrigan

Starting and growing a business is challenging, even in the best of times. But these are not the best of times, and Congress could soon make it even harder for small businesses to compete and grow.

A bill from Senators Patrick Leahy (D-VT), Thom Tillis (R-NC), and John Cornyn (R-TX) is gaining momentum -- and if it passes, big corporations will find it easier to pilfer their smaller competitors' patented ideas and designs. The "Patent Trial and Appeal Board Reform Act of 2022," as the bill is called, could snuff out many of the small firms -- and much of the innovation -- that power America's economy.

Congress created the Patent Trial and Appeal Board back in 2011 with the best of intentions. Their aim? To create a suitable, cost-effective alternative to the court system for parties to settle patent disputes.

But bad actors quickly twisted this system into a platform to challenge -- and ultimately invalidate -- their competitors' patents. Corporate behemoths sometimes infringe on their smaller competitors' patents. When those competitors sue in district court, on patent infringement claims, larger companies turn around and challenge the very existence of these asserted patents at the PTAB. This essentially forces small firms to fight a war on two fronts to defend their intellectual property.

This strategy has worked remarkably well, and to the detriment of many small firms. In the decade since it was founded, the PTAB has at least partially invalidated 84% of the patents it has fully reviewed.

To remedy some of this problem, the U.S. Patent and Trademark Office implemented what it calls the Fintiv factors, a set of guidelines established after its 2020 Apple v. Fintiv decision that allows the PTAB to decline to review a patent challenge if the patent in question is already the focus of a patent infringement case moving in federal court.

Fortunately for small businesses, the Fintiv factors curtailed predatory tactics by larger companies. Shortly after Fintiv was first enforced, the number of patent challenges heard by the PTAB fell by 40%.

Now, Senators Tillis, Leahy, and Cornyn are moving forward with legislation that will hurt small inventors. Their PTAB Reform Act would effectively invalidate the Fintiv factors, stripping protections away from small businesses and subjecting them to years of legal proceedings at the hands of well-funded rivals.

Few small businesses will have the financial backing to weather parallel legal storms -- and the consequences on innovation and entrepreneurship will be disastrous.

Without strong intellectual-property protections, many new businesses would fail to launch. As every entrepreneur knows, building a business is a high-risk endeavor. By licensing proprietary technologies, business owners reduce risk and attract investors with the promise of exclusive rights to sell a successful product.

It's encouraging to see lawmakers making patent-system reform a priority. But the model that Senators Leahy, Tillis, and Cornyn propose will send unintended shockwaves through our nation's most innovative sector. Small businesses account for six out of 10 jobs in America. That's something lawmakers would do well to remember when, and if, the misguided PTAB Reform Act comes to a vote. Karen Kerrigan is president and CEO of the Small Business & Entrepreneurship Council. This article originally appeared on InsideSources.com.



More Resources


03/28/2024
The Democrats' Abundance Problem Revisited
So, Um, Where Is It?

more info


03/28/2024
Are Democrats Still Stuck With Biden?


more info


03/28/2024
RFK Jr. Now Hurting Biden, Helping Trump


more info


03/28/2024
The Twilight of the Republican 'McLeadership'
The Trump team is steadily purging the Republican leadership of holdovers from past decades. The departure of McCarthy, McDaniel, and McConnell is part of exorcising the legacy of a more important Mc whose influence is still felt in the U.S. Senate: John McCain.

more info


03/28/2024
The Funniest Media Story of the Year?
Surely this is the funniest media story of the year?

more info


03/28/2024
Abridging, Not Coercing, Is First Amendment's Yardstick
Under the First Amendment, the government may not abridge the freedom of speech, whether that abridging is done by coercing internet platforms or by getting them to cooperate in government efforts to censor the public.

more info


03/28/2024
Trade Cheaters Are Killing Aluminum Industry Jobs
Aluminum industry workers stand ready to do their part to move the nation forward. They just need the federal government to enforce trade laws.

more info


03/28/2024
It's Time for an Immigration Moratorium
An effective freeze on immigration could revitalize our national culture, politics, and economy before it's too late.

more info


03/28/2024
U.N. Gaza Resolution Could Lead to Lasting Cease-Fire


more info


03/28/2024
Biden's War Against the Jews


more info


03/28/2024
'Fairness Initiative' Tackles Too-High Government Pay
Governments at every level ought to cap public-sector wages and benefits at private-sector comparables.

more info


03/28/2024
My Friend Joe
I write now, in the worst pain and shock, with news of my friend Joe Lieberman's death just moments ago. I write because I know what his critics will be quick to write, what news reports have already re-circulated.

more info


03/28/2024
Why I'm Resigning From the Biden State Department
Since Hamas' attack on October 7, Israel has used American bombs in its war in Gaza, which has killed more than 32,000 people - 13,000 of them children - with countless others buried under the rubble, according to the Gaza Ministry of Health. Israel is credibly accused of starving the 2 million people who remain, according to the UN special rapporteur on the right to food; a group of charity leaders warns that without adequate aid, hundreds of thousands more will soon likely join the dead.

more info


03/28/2024
Gaza: Truths Behind All the Lies
From civilian casualties, the use of disproportionate force, and international biases, the mainstream narrative of the Gaza conflict often obfuscates the truth behind lies.

more info


03/28/2024
Obama, Fearing Biden Loss to Trump, Is On Phone To Strategize
As the election approaches, President Joe Biden is making regular calls to former President Barack Obama to catch up on the race or to talk about family. But Obama is making calls of his own to Jeffrey Zients, the White House chief of staff, and to top aides at the Biden campaign to strategize and relay advice.

more info



Custom Search

More Politics Articles:

Related Articles

Trump's Socialist Attack on Americans' Health and Medical INnovations Must Be Stopped


Imagine if Barack Obama signed an executive order implementing socialist price controls on prescription drugs. And suppose that decision limited the drugs available to patients, dried up funding for innovative new treatments and resulted in the unnecessary deaths of thousands of Americans a year.

Biden Won't Win Votes by Threatening Swing State Jobs


It sometimes seems as if former Vice President Biden is hell bent on losing this November.

New Drug Pricing Executive Order Burdens Patients


President Trump just signed an executive order designed to reduce drug prices. Dubbed a "Most Favored Nations" policy, the order pegs Medicare payments for medicines to the prices paid by foreign governments.

Enjoy Your Usual Life, But Vote


Occasionally we all feel like we are living in a rut. Our days and weeks are filled with the same activities and schedules. We mow grass, rake leaves, clean the house, sweep out the garage and do the same jobs. We go to the same grocery store on a certain day, wash our car at the same place and see the same people along the way. We go to the same place of worship, and read the same daily or weekly newspaper. Our lives are made up of routines, schedules and the usual.

The Sun is Shining


The Sun is shining today and will rise tomorrow. For more years than we know the Sun has followed this same pattern.

Giving Thanks to Society’s Economic Benefactors


With all the attention commanded by the presidential campaign, election, and aftermath, plus the ongoing COVID-19 story, many other issues have faded into the background. Though escaping the headlines, some of these other issues will be with us for a long time, and contributions to the public discussion of such issues will often have a long-term impact.

Importing Drugs Endangers Lives


On most issues, Democrats and Republicans remain deeply divided. But there's one policy that unites both -- prescription drug importation.

On the Impeachment and Conviction of President Trump


The House of Representatives, with the sole responsibility of impeachment, has passed a single Article of Impeachment charging President Donald Trump with committing a high crime, namely that he “made statements that encouraged—and foreseeably resulted in—imminent lawless action at the Capitol.” In short, his rally speech, it is claimed, amounted to “incitement to engage in the insurrection.”

Death of a Defector: Ion Mihai Pacepa, RIP


On February 14, 2021, the world quietly lost one of the most intriguing, enduring figures of the Cold War. He was Lt. Gen. Ion Mihai Pacepa, the highest-ranking Soviet Bloc official ever to defect to the United States.

Stop Businesses From Exploiting This Health Program for the Poor


Over the decades, Congress has created a number of programs intended to help the poor, the sick, the downtrodden. As a result, certain businesses and industries find ways to exploit these efforts and profit in ways lawmakers never foresaw or intended.

Preventing the Next Public Health Crisis Can Define Biden's Legacy


The Biden administration's plan to defeat the coronavirus is underway -- and notably includes intentions to "build better preparedness for future threats." This detailed guidance could not have come at a better time. While we are making progress against the current pandemic, we remain in the midst of a worsening health crisis posed by antibiotic resistance.

For Seniors' Sake, Protect the Innovation that Brought Us Covid Vaccines


The breakneck pace of Covid-19 vaccine development will go down in history books as one of the great triumphs of modern medicine.

Raise the Corporate Tax Rate? Economic Obtuseness in High Places


Having proposed trillions of dollars of additional federal spending, President Joe Biden and allies have launched a belated and somewhat desperate search for additional tax revenues. The economic reality is that there simply isn’t enough wealth available in the private sector to fund the explosion in government spending. The danger is that changes in the tax code may do more damage than good.

America's Goose that Lays the Golden Eggs


America's research and development institutions have long been the envy of our competitors, flourishing at the top of global rankings. But our state-of-the-art innovation capabilities — responsible for bringing COVID-19 vaccines and countless other breakthroughs to market — haven't flourished here by happenstance. They have been nurtured over decades of smart policies, and those policies are now at risk.

A Public Option Will Destroy Private Insurance


Congress is trying to chart a path forward on health reform. Several congressional Democrats just announced plans to draft a bill that would create a public health insurance option.